244 related articles for article (PubMed ID: 7992018)
1. Prevalence of HBeAg and HBsAg seroconversion in patients with chronic hepatitis B.
Stránský J; Chlumská A; Zichová M; Helm R; Mankovecký L; König J
Sb Lek; 1993; 94(4):317-25. PubMed ID: 7992018
[TBL] [Abstract][Full Text] [Related]
2. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
Chlumská A; Stránský J; Taimr P; Baumruk L; Nevaril M
Vnitr Lek; 1995 Jul; 41(7):445-8. PubMed ID: 7571477
[TBL] [Abstract][Full Text] [Related]
3. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A
Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B].
Kim JM; Choe BH; Chu MA; Cho SM
Korean J Hepatol; 2009 Jun; 15(2):168-78. PubMed ID: 19581769
[TBL] [Abstract][Full Text] [Related]
5. Clinical importance of assessment of HBsAg/IgM complexes in chronic hepatitis B.
Stránský J; Vodák M; Zichová M
Acta Virol; 1993; 37(2-3):170-4. PubMed ID: 8105661
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
[TBL] [Abstract][Full Text] [Related]
7. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
Kao JH; Chen PJ; Lai MY; Chen DS
J Med Virol; 2004 Mar; 72(3):363-9. PubMed ID: 14748059
[TBL] [Abstract][Full Text] [Related]
9. Seroconversion of HBsAg in HBeAg positive and HBeAg negative patients with chronic HBV treated with entecavir: a case series.
d'Ettorre G; Barbarini G; Corti F; Gobber M; Pastecchia C; Ricci GL; Siciliano M; Annicchiarico BE; Vullo V
Eur Rev Med Pharmacol Sci; 2010 Jun; 14(6):551-4. PubMed ID: 20712263
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
Chen DS; Sung JL; Lai MY
Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
[TBL] [Abstract][Full Text] [Related]
11. [Mid-term natural course in Naples of chronic HBeAg positive infection caused by the HB-virus. Prospective study, preliminary to antiviral treatment].
Canestrini C; Amitrano L; Ascione A; De Lella A; De Luca M; Ferbo U; Riccio E; Gigliotti T
Minerva Dietol Gastroenterol; 1989; 35(2):119-22. PubMed ID: 2761751
[TBL] [Abstract][Full Text] [Related]
12. Investigations on HBe antigen. Note II. Dynamics of HBsAg in acute viral hepatitis, according to HBeAg persistence or seroconversion.
Babeş VT; Cepănaru S; Cepănaru R; Tănase M
Virologie; 1981; 32(3):187-91. PubMed ID: 7303492
[TBL] [Abstract][Full Text] [Related]
13. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age.
Chang MH; Hsu HY; Hsu HC; Ni YH; Chen JS; Chen DS
Hepatology; 1995 Nov; 22(5):1387-92. PubMed ID: 7590652
[TBL] [Abstract][Full Text] [Related]
14. [Clinico-prognostic significance of partial seroconversion in chronic viral hepatitis B follow-up. Wartenbert Study (1974-1994), II].
Ohlen I; Liegl JM; Selmair H
Leber Magen Darm; 1995 Dec; 25(6):259-62. PubMed ID: 8577215
[TBL] [Abstract][Full Text] [Related]
15. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
[TBL] [Abstract][Full Text] [Related]
16. [Durability of HBeAg seroconversion in lamivudine treatment of chronic hepatitis B patients].
Zhu M; Xu B; Yao GB
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):534-6. PubMed ID: 16042894
[TBL] [Abstract][Full Text] [Related]
17. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels.
Chu CM; Hung SJ; Lin J; Tai DI; Liaw YF
Am J Med; 2004 Jun; 116(12):829-34. PubMed ID: 15178498
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
Hsu YS; Chien RN; Yeh CT; Sheen IS; Chiou HY; Chu CM; Liaw YF
Hepatology; 2002 Jun; 35(6):1522-7. PubMed ID: 12029639
[TBL] [Abstract][Full Text] [Related]
19. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer.
Lau GK; Lok AS; Liang RH; Lai CL; Chiu EK; Lau YL; Lam SK
Hepatology; 1997 Jun; 25(6):1497-501. PubMed ID: 9185774
[TBL] [Abstract][Full Text] [Related]
20. [Anti-HBs-F(ab)'2 to the seroconversion of HBsAg carriers].
An P
Zhonghua Yi Xue Za Zhi; 1992 Nov; 72(11):647-50, 701. PubMed ID: 1338699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
